# Guidance for Industry:  Suicidal Ideation and Behavior:  Prospective Assessment of Occurrence in Clinical Trials - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/guidance-for-industry-suicidal-ideation-and-behavior-prospective-assessment-of-occurrence-in-clinical-trials/c258943d-f6d1-4ddb-b590-e1b38509aab4

> FDA guidance document: Guidance for Industry:  Suicidal Ideation and Behavior:  Prospective Assessment of Occurrence in Clinical Trials. Issue date: August 13, 2012. Get complete insights and analysis.

---

## Details

- Title: Guidance for Industry:  Suicidal Ideation and Behavior:  Prospective Assessment of Occurrence in Clinical Trials
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2012-08-13
- Last Changed: 2022-02-25

## Related Documents

- [Alcoholism:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/alcoholism-developing-drugs-for-treatment/5dd607ce-ea00-4415-bc0a-e05b7963322b)
- [Assessment of Pressor Effects of Drugs Guidance for Industry: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/assessment-of-pressor-effects-of-drugs-guidance-for-industry-draft-guidance-for-industry/35abdc27-8b6a-4eb0-ba74-78a4a3840a3d)
- [Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/gastroparesis-clinical-evaluation-of-drugs-for-treatment-guidance-for-industry/4b7bc445-8e11-4ce8-a6d6-3439f06daab5)